Literature DB >> 8673743

Class III Antiarrhythmics: put to the SWORD?

S M Cobbe.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8673743      PMCID： PMC484241          DOI： 10.1136/hrt.75.2.111

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  24 in total

1.  Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases.

Authors:  A Bayés de Luna; P Coumel; J F Leclercq
Journal:  Am Heart J       Date:  1989-01       Impact factor: 4.749

2.  Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction. A prospective study.

Authors:  M T La Rovere; G Specchia; A Mortara; P J Schwartz
Journal:  Circulation       Date:  1988-10       Impact factor: 29.690

3.  Decreased heart rate variability and its association with increased mortality after acute myocardial infarction.

Authors:  R E Kleiger; J P Miller; J T Bigger; A J Moss
Journal:  Am J Cardiol       Date:  1987-02-01       Impact factor: 2.778

4.  Beta blockade during and after myocardial infarction: an overview of the randomized trials.

Authors:  S Yusuf; R Peto; J Lewis; R Collins; P Sleight
Journal:  Prog Cardiovasc Dis       Date:  1985 Mar-Apr       Impact factor: 8.194

5.  Controlled trial of sotalol for one year after myocardial infarction.

Authors:  D G Julian; R J Prescott; F S Jackson; P Szekely
Journal:  Lancet       Date:  1982-05-22       Impact factor: 79.321

6.  Analysis of cardiac symptoms preceding cardiac arrest.

Authors:  S Goldstein; S V Medendorp; J R Landis; R A Wolfe; R Leighton; G Ritter; C M Vasu; A Acheson
Journal:  Am J Cardiol       Date:  1986-12-01       Impact factor: 2.778

7.  The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.

Authors:  J T Bigger; J L Fleiss; R Kleiger; J P Miller; L M Rolnitzky
Journal:  Circulation       Date:  1984-02       Impact factor: 29.690

8.  Class III antiarrhythmic action linked with positive inotropy: effects of the d- and l-isomer of sotalol on isolated rat atria at threshold and suprathreshold stimulation.

Authors:  P M Tande; H Refsum
Journal:  Pharmacol Toxicol       Date:  1988-05

9.  The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.

Authors:  P T Sager; C Follmer; P Uppal; C Pruitt; R Godfrey
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

10.  Re-entrant ventricular arrhythmias in the late myocardial infarction period. 4. Mechanism of action of lidocaine.

Authors:  N El-Sherif; B J Scherlag; R Lazzara; R R Hope
Journal:  Circulation       Date:  1977-09       Impact factor: 29.690
View more
  3 in total

1.  Inadequate ischaemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischaemia and reperfusion in the rat isolated perfused heart.

Authors:  A Farkas; A Qureshi; M J Curtis
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 2.  Phase 2 ventricular arrhythmias in acute myocardial infarction: a neglected target for therapeutic antiarrhythmic drug development and for safety pharmacology evaluation.

Authors:  Hugh Clements-Jewery; David J Hearse; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

Review 3.  Drug-induced cardiac arrhythmias: incidence, prevention and management.

Authors:  J C Doig
Journal:  Drug Saf       Date:  1997-10       Impact factor: 5.228
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.